<ѻýҕl>Mepitel Film Beats Standard for Stopping Radiation Dermatitis in Breast Cancerѻýҕl> "The most improvement in skin toxicity that I have seen in many years," expert says Oct 19, 2022
<ѻýҕl>Risk of Secondary Breast Cancer After Childhood Cancer Is Declining, Study Suggestsѻýҕl> Improvement credited to changes in chest RT, attenuated by use of pelvic RT, anthracyclines Oct 13, 2022
<ѻýҕl>This One Risk Factor Dominates for Soft Tissue Sarcoma After Breast Cancerѻýҕl> Risk is low but appears to have modifiable components Oct 13, 2022
<ѻýҕl>Katie Couric's Breast Cancerѻýҕl> The popular media personality is on a mission to raise awareness around dense breasts Oct 06, 2022
<ѻýҕl>Hand Cooling, Compression Both Effective for Nerve Pain in Breast Cancerѻýҕl> But access, cost, and tolerability may favor the latter option, said researcher Sep 14, 2022
<ѻýҕl>Denosumab Halts Bone Loss From Ovarian Suppression, AIs for Breast Cancerѻýҕl> Areal BMD increased when given at the start of maximal estradiol depletion therapy Sep 13, 2022
<ѻýҕl>Targeted Combo Flops as First-Line Treatment in Advanced Breast Cancerѻýҕl> No clinical benefit boost with anti-CD73 oleclumab added to durvalumab and chemo Sep 10, 2022
<ѻýҕl>Antibody-Drug Conjugate Prolongs Survival in Metastatic Breast Cancerѻýҕl> Positive outcome with sacituzumab govitecan leads to questions about ADC sequencing Sep 09, 2022
<ѻýҕl>2 Years of Endocrine Therapy, 2 Decades of Protection From Metastatic Breast Cancerѻýҕl> Tamoxifen protects low-risk premenopausal patients, goserelin helps high-risk patients Aug 31, 2022
<ѻýҕl>Hearing Loss Plagues Cancer Survivors No Matter the Type of Chemoѻýҕl> Ototoxicity reported in more than half of study patients who got platinum, taxanes, or both Aug 03, 2022
<ѻýҕl>Lessons From a Lifelong Patient Turned Oncologistѻýҕl> Eric Winer, MD, talks about how growing up with hemophilia helped him connect with patients Aug 02, 2022 podcast
<ѻýҕl>Do Therapy-Related Hot Flashes in Breast Cancer Signal Worse Outcomes?ѻýҕl> Swedish study finds reduced DFS in women who used drugs for hot flashes Jun 22, 2022
<ѻýҕl>Diabetes Threatens Long-Term Survival in Metastatic Breast Cancerѻýҕl> 5-year survival rates were not affected, however Jun 13, 2022
<ѻýҕl>A Better Way to Irradiate Lethal CNS Metastases?ѻýҕl> Randomized trial makes case for proton craniospinal irradiation for leptomeningeal spread Jun 08, 2022
<ѻýҕl>Forego Radiotherapy for Women With Low-Risk Luminal A Breast Cancer?ѻýҕl> Study shows 5-year local recurrence rate of 2.3% with lumpectomy and endocrine therapy alone Jun 07, 2022
<ѻýҕl>Endocrine Switch Plus Ribociclib Active in Post-CDK4/6 Inhibitor Progressionѻýҕl> First randomized support for strategy in progressive metastatic HR+/HER2- breast cancer Jun 06, 2022
<ѻýҕl>Trastuzumab Deruxtecan Ushers in New Treatment Era for HER2-Low Breast Cancerѻýҕl> DESTINY-Breast04 extends agent's benefits to historically tough-to-treat disease Jun 05, 2022
<ѻýҕl>Capivasertib-Fulvestrant Combo Ups Survival in ER+/HER2- Metastatic Breast Cancerѻýҕl> But benefit seems to be predominantly in patients with PI3K/AKT/PTEN pathway alterations Jun 05, 2022
<ѻýҕl>Sacituzumab Govitecan Boosts PFS in Late-Line HR+/HER2- Metastatic Breast Cancerѻýҕl> "This may be something that really changes the lives of these women for the better," expert says Jun 05, 2022
<ѻýҕl>Adjuvant Everolimus Fails to Stop Recurrence in Early High-Risk Breast Cancerѻýҕl> More than half of everolimus-treated patients permanently discontinued treatment Jun 02, 2022
<ѻýҕl>Prone Beats Supine Positioning for WBRT in Women With Large Breastsѻýҕl> Prone position led to lower rates of moist desquamation May 27, 2022
<ѻýҕl>Black Patients Often Never Given a Chance to Join Breast Cancer Trialsѻýҕl> But survey finds several actionable findings that could boost enrollment May 26, 2022
<ѻýҕl>Vaginal Estrogen 'Underutilized' in Women With GSM After Breast Cancerѻýҕl> Prescribing rate is half that of women with no breast cancer history May 13, 2022
<ѻýҕl>Novel Combo Falters in Metastatic Triple-Negative Breast Cancerѻýҕl> No PFS benefit with addition of ceralasertib to olaparib May 05, 2022
<ѻýҕl>Screening, Early Detection Remain Keys to Lower Cancer Mortalityѻýҕl> Presidential panel sets course to remove barriers, increase services, and improve uptake May 05, 2022
<ѻýҕl>Antibody-Drug Conjugate Promising for Breast Cancer With Brain Metsѻýҕl> High intracranial response rates with trastuzumab-deruxtecan observed in TUXEDO-1 trial May 04, 2022
<ѻýҕl>Young Cancer Survivors Face Higher Risk of Death From Second Malignanciesѻýҕl> Study finds 25% higher risk of secondary cancers versus general public, 84% higher risk of death May 04, 2022
<ѻýҕl>Menstrual Cycles Point to Link Between Sex Hormones and Long QTѻýҕl> Research suggests new tools for risk stratification and therapy May 01, 2022
<ѻýҕl>DCIS Recurrence Often Represents a New Primary Breast Cancerѻýҕl> Almost a fifth of cases unrelated to primary DCIS, raising questions about current treatment Apr 11, 2022
<ѻýҕl>RT Prior to Mastectomy, Reconstruction Shows Promiseѻýҕl> U.K. study demonstrates low complication rates and good aesthetic results Apr 08, 2022
<ѻýҕl>Is Sentinel Node Biopsy Necessary for Older Breast Cancer Patients?ѻýҕl> Study finds positive lymph nodes not an indicator for chemotherapy Apr 07, 2022
<ѻýҕl>New Clue to Risk of Peritoneal Cancer After Prophylactic Salpingo-Oophorectomyѻýҕl> Women with BRCA variant and serous tubal intraepithelial carcinoma had a 34-fold greater risk Apr 05, 2022
<ѻýҕl>3D Mammograms Deliver Fewer False-Positive Findingsѻýҕl> However, half of women will have a false positive with annual screening with DBT Mar 25, 2022
<ѻýҕl>Artificial Sweeteners Not So Sweet When It Comes to Cancer Riskѻýҕl> Consumption of certain sugar alternatives linked to a 13% higher risk of developing cancer Mar 24, 2022
<ѻýҕl>FDA OKs PARP Inhibitor as Adjuvant Therapy in Early Breast Cancerѻýҕl> Olaparib (Lynparza) approved for high-risk patients with germline BRCA mutations Mar 14, 2022
<ѻýҕl>Fluorescence-Guided Lumpectomy Shows Promiseѻýҕl> Imaging system reduced the need for re-excision in one-fifth of patients Mar 11, 2022
<ѻýҕl>Androgen Receptor Agonist Active in Resistant ER+ Breast Cancerѻýҕl> Also: Combination targets uncommon form of advanced HER2-mutant disease Mar 09, 2022
<ѻýҕl>More Options for Precision Medicine in Metastatic Triple-Negative Breast Cancerѻýҕl> Moving beyond chemotherapy to immunotherapy, PARP inhibitors, ADCs, combinations Mar 08, 2022
<ѻýҕl>Chipping Away at the Dogma of Axillary Dissection in Breast Cancerѻýҕl> Ongoing trials could help some women avoid even less-invasive sentinel lymph node biopsy Mar 07, 2022
<ѻýҕl>Clinical Picture Brightens for HER2+ Breast Cancer With Brain Metastasesѻýҕl> New therapies breach blood-brain barrier to improve response, survival Mar 07, 2022